SCHEMBL26323291

SCHEMBL26323291

CNC(=O)c1cc2c(I)c(C)c(OC)cc2n1C

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.40
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 3/20 0.37
TSHR P16473 3/20 0.37
HSD17B10 Q99714 3/20 0.37
LMNA P02545 2/20 0.37
TP53 P04637 1/20 0.37
BRPF1 P55201 2/20 0.36
BRD4 O60885 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
RXFP1 Q9HBX9 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MAPK1 P28482 2/20 0.35
HPGD P15428 2/20 0.35
ESR1 P03372 1/20 0.35
GLA P06280 1/20 0.35
PLK1 P53350 1/20 0.35
PHGDH O43175 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2272984 0.75 KDM4E (0.51) MAPTKDM4EALDH1A1TSHRHSD17B10
SCHEMBL19331463 0.71 L3MBTL1 (0.46) KDM4EALDH1A1MEN1KMT2ARXFP1
SCHEMBL19331371 0.69 HSD17B10 (0.43) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL2275127 0.67 SLC9A1 (0.59) MAPTKDM4EALDH1A1TSHRHSD17B10
SCHEMBL2902799 0.66 L3MBTL1 (0.49) KDM4EALDH1A1HSD17B10RXFP1L3MBTL1
SCHEMBL1004083 0.66 RXFP1 (0.68) MAPTKDM4EALDH1A1TSHRLMNA
SCHEMBL2277189 0.65 L3MBTL1 (0.58) MAPTKDM4EALDH1A1TSHRHSD17B10
SCHEMBL9514737 0.65 L3MBTL1 (0.76) MAPTKDM4EALDH1A1HSD17B10LMNA
SCHEMBL19332523 0.65 L3MBTL1 (0.48) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL2905589 0.64 ALDH1A1 (0.60) KDM4EALDH1A1HSD17B10LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4234552-A2 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF Raze Therapeutics, Inc. (US) 2023-08-30 EP disclosed